Sleep Disorders: Promotion and Awareness Will Drive Market Growth

Table of Contents

• Introduction
• Overview of Insomnia
• Etiology and Prevalence
• Current Therapies
• Benzodiazepines
• Non-Benzodiazepines
• Melatonin Antagonists
• Narcolepsy
• Etiology and Prevalence
• Current Treatments
• Restless Legs Syndrome
• Etiology and Prevalence
• Current Treatments
• Sleep Apnea
• Etiology and Prevalence
• Current Treatments
• The Sleep Disorders Market
• Emerging Therapies
• Insomnia
• 5-HT2a Antagonists
• GABA Agonists
• H1 Antagonists
• Melatonin Agonists
• Narcolepsy
• Restless Legs Syndrome
• Sleep Apnea
• Market Outlook
• United States
• Europe
• Japan

• Table 1 Prevalence of Sleep Disorders, 2005
• Table 2 Sales of Leading Agents for the Treatment of Sleep Disorders, 2005
• Table 3 Agents in Development for Treatment of Insomnia, 2006
• Table 4 Agents in Development for the Treatment of Narcolepsy, Restless Legs Syndrome, and Sleep Apnea
• Table 5 Forecasted Sales of Drugs for the Treatment of Sleep Disorders in the Three Major-Market Regions, 2010 and 2015